274 related articles for article (PubMed ID: 27758943)
1. Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation: An Observational Cohort Study.
Bonde AN; Lip GY; Kamper AL; Fosbøl EL; Staerk L; Carlson N; Torp-Pedersen C; Gislason G; Olesen JB
Stroke; 2016 Nov; 47(11):2707-2713. PubMed ID: 27758943
[TBL] [Abstract][Full Text] [Related]
2. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
[TBL] [Abstract][Full Text] [Related]
3. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
4. Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries.
Bonde AN; Lip GYH; Kamper AL; Staerk L; Torp-Pedersen C; Gislason G; Olesen JB
Thromb Haemost; 2017 Dec; 117(12):2291-2299. PubMed ID: 29212117
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis.
Hijazi Z; Hohnloser SH; Oldgren J; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Reilly PA; Siegbahn A; Yusuf S; Wallentin L
Circulation; 2014 Mar; 129(9):961-70. PubMed ID: 24323795
[TBL] [Abstract][Full Text] [Related]
6. Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation.
Shin JI; Secora A; Alexander GC; Inker LA; Coresh J; Chang AR; Grams ME
Clin J Am Soc Nephrol; 2018 Aug; 13(8):1144-1152. PubMed ID: 30002224
[TBL] [Abstract][Full Text] [Related]
7. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
Szummer K; Gasparini A; Eliasson S; Ärnlöv J; Qureshi AR; Bárány P; Evans M; Friberg L; Carrero JJ
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28249846
[TBL] [Abstract][Full Text] [Related]
8. The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study.
Jun M; James MT; Manns BJ; Quinn RR; Ravani P; Tonelli M; Perkovic V; Winkelmayer WC; Ma Z; Hemmelgarn BR;
BMJ; 2015 Feb; 350():h246. PubMed ID: 25647223
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis.
Bai Y; Deng H; Shantsila A; Lip GY
Stroke; 2017 Apr; 48(4):970-976. PubMed ID: 28213573
[TBL] [Abstract][Full Text] [Related]
10. Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation.
Jun M; James MT; Ma Z; Zhang J; Tonelli M; McAlister FA; Manns BJ; Ravani P; Quinn RR; Wiebe N; Perkovic V; Wilton SB; Winkelmayer WC; Hemmelgarn BR;
Am J Kidney Dis; 2017 Jun; 69(6):734-743. PubMed ID: 27998624
[TBL] [Abstract][Full Text] [Related]
11. Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study.
Brønnum Nielsen P; Larsen TB; Gorst-Rasmussen A; Skjøth F; Rasmussen LH; Lip GYH
Chest; 2015 Jun; 147(6):1651-1658. PubMed ID: 25412369
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Fauchier L; Vourc'h P; Andres CR; Taillandier S; Halimi JM; Lip GYH
Chest; 2014 Jun; 145(6):1370-1382. PubMed ID: 24356875
[TBL] [Abstract][Full Text] [Related]
13. Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation.
Becattini C; Giustozzi M; Ranalli MG; Bogliari G; Cianella F; Verso M; Agnelli G; Vedovati MC
J Thromb Haemost; 2018 May; 16(5):833-841. PubMed ID: 29460334
[TBL] [Abstract][Full Text] [Related]
14. Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Fauchier L; Vourc'h P; Andres CR; Taillandier S; Halimi JM; Lip GY
J Am Coll Cardiol; 2013 May; 61(20):2079-87. PubMed ID: 23524209
[TBL] [Abstract][Full Text] [Related]
15. Lower-dose warfarin delays renal progression and prolongs patient survival in patients with stage 3 - 5 chronic kidney disease and nonvalvular atrial fibrillation: a 12-year follow-up study.
Chiu PF; Huang CH; Liou HH; Wu CL; Chang C; Chang CC; Chang HR
Int J Clin Pharmacol Ther; 2014 Jun; 52(6):504-8. PubMed ID: 24755133
[TBL] [Abstract][Full Text] [Related]
16. Stroke and bleeding in atrial fibrillation with chronic kidney disease.
Olesen JB; Lip GY; Kamper AL; Hommel K; Køber L; Lane DA; Lindhardsen J; Gislason GH; Torp-Pedersen C
N Engl J Med; 2012 Aug; 367(7):625-35. PubMed ID: 22894575
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
[TBL] [Abstract][Full Text] [Related]
18. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
[TBL] [Abstract][Full Text] [Related]
19. Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation.
Chan PH; Huang D; Hai JJ; Li WH; Yin LX; Chan EW; Wong IC; Lau CP; Chiang CE; Zhu J; Tse HF; Siu CW
Heart Rhythm; 2016 Feb; 13(2):366-73. PubMed ID: 26392326
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.
Larsen TB; Rasmussen LH; Skjøth F; Due KM; Callréus T; Rosenzweig M; Lip GY
J Am Coll Cardiol; 2013 Jun; 61(22):2264-73. PubMed ID: 23562920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
